Usman MS, Bhatt DL, Hameed I, Anker SD, Cheng AYY, Hernandez AF, et al
Beltre says
Within the same period, the dispensed prescriptions within the benefit to incident patients with a preexisting diagnosis of obesity without T2DM increased by 270% (4.0 to 14.6%), and 502% for patients with neither obesity nor T2DM (5.3 to 32.1%), and 515% for patients without any of the included diagnoses (4.2 to 25.7%) (see Table 9 in the Appendix)
Glutathione in foods listed in National Health Habits and History Food Frequency Questionnaires
Patients taking GLP1-RA for longer than 180 days had the incidence of anxiety reduced to 2.93 per 1,000 person-years, with an aHR of 0.41 (95%CI: 0.270.61), compared to non-users